• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXHL1500196 磷酸芦可替尼片 ruxolitinib phosphate Tablet Chemical Drugs Import Drug Application 2015-07-31 Novartis Pharma AG Novartis Pharma Schweiz AG Certificate Issued 2016-08-02 view
JXHL1600052 磷酸芦可替尼片 ruxolitinib phosphate Tablet Chemical Drugs Import Drug Application 2016-04-18 Novartis Pharma AG Novartis Pharma Schweiz AG Certificate Issued 2016-11-08 view
JXHL1600042 磷酸芦可替尼片 ruxolitinib phosphate Tablet Chemical Drugs Import Drug Application 2016-04-06 Novartis Pharma AG Novartis Pharma Schweiz AG Certificate Issued 2016-11-17 view
JXHL1600043 磷酸芦可替尼片 ruxolitinib phosphate Tablet Chemical Drugs Import Drug Application 2016-03-31 Novartis Pharma AG Novartis Pharma Schweiz AG Certificate Issued 2016-11-17 view
JXHL1700141 磷酸芦可替尼片 ruxolitinib phosphate Tablet Chemical Drugs(2.4) Import Drug Application 2017-08-09 Novartis Pharma AG Novartis Pharma Schweiz AG Certificate Issued 2018-05-21 view
JXHL1500197 磷酸芦可替尼片 ruxolitinib phosphate Tablet Chemical Drugs Import Drug Application 2015-08-07 Novartis Pharma AG Novartis Pharma Schweiz AG Certificate Issued 2016-08-02 view
JXHL1700142 磷酸芦可替尼片 ruxolitinib phosphate Tablet Chemical Drugs(2.4) Import Drug Application 2017-07-29 Novartis Pharma AG Novartis Pharma Schweiz AG Certificate Issued 2018-06-12 view
JXHL1600053 磷酸芦可替尼片 ruxolitinib phosphate Tablet Chemical Drugs Import Drug Application 2016-04-11 Novartis Pharma AG Novartis Pharma Schweiz AG Certificate Issued 2016-11-08 view
JYHZ0800007 盐酸马普替林 maprotiline hydrochloride Active ingredient Chemical Drugs License Renew 2008-01-15 Novartis Pharma AG Novartis Pharma Schweiz AG Certificate Issued 2008-08-06 view
JXHL1300293 注射用帕瑞肽 pasireotide diaspartate Lyophilized Chemical Drugs Import Drug Application 2013-08-09 Novartis Pharma AG Novartis Pharma Schweiz AG Certificate Issued 2015-01-30 view
JYHB1101024 注射用帕瑞肽 pasireotide diaspartate Lyophilized Chemical Drugs Supplementary Application 2011-12-08 Novartis Pharma AG Novartis Pharma Schweiz AG Certificate Issued 2012-07-12 view
JXHL1400112 注射用帕瑞肽 pasireotide diaspartate Lyophilized Chemical Drugs Import Drug Application 2014-04-11 Novartis Pharma AG Novartis Pharma Schweiz AG Certificate Issued 2015-05-19 view
JXHL1100351 注射用帕瑞肽 pasireotide diaspartate Lyophilized Chemical Drugs Import Drug Application 2011-10-10 Novartis Pharma AG Novartis Pharma Schweiz AG Certificate Issued 2012-11-13 view
JYHB0800836 注射用帕瑞肽 pasireotide diaspartate Lyophilized Chemical Drugs Supplementary Application 2009-01-04 Novartis Pharma AG Novartis Pharma Schweiz AG Certificate Issued 2009-06-16 view
JXHL1400113 注射用帕瑞肽 pasireotide diaspartate Lyophilized Chemical Drugs Import Drug Application 2014-04-03 Novartis Pharma AG Novartis Pharma Schweiz AG Certificate Issued 2015-05-19 view
JYHB0800835 注射用帕瑞肽 pasireotide diaspartate Lyophilized Chemical Drugs Supplementary Application 2009-01-04 Novartis Pharma AG Novartis Pharma Schweiz AG Certificate Issued 2009-06-16 view
JXHL1300294 注射用帕瑞肽 pasireotide diaspartate Lyophilized Chemical Drugs Import Drug Application 2013-08-02 Novartis Pharma AG Novartis Pharma Schweiz AG Certificate Issued 2015-01-30 view
JYHB1000041 注射用帕瑞肽 pasireotide diaspartate Lyophilized Chemical Drugs Supplementary Application 2010-02-23 Novartis Pharma AG Novartis Pharma Schweiz AG Certificate Issued 2010-07-20 view
JXHL1100350 注射用帕瑞肽 pasireotide diaspartate Lyophilized Chemical Drugs Import Drug Application 2011-10-24 Novartis Pharma AG Novartis Pharma Schweiz AG Certificate Issued 2012-11-13 view
JYHB0800834 注射用帕瑞肽 pasireotide diaspartate Lyophilized Chemical Drugs Supplementary Application 2009-01-04 Novartis Pharma AG Novartis Pharma Schweiz AG Certificate Issued 2009-06-16 view